Oruka Therapeutics (ORKA) Change in Acquisitions & Divestments (2016 - 2026)
Oruka Therapeutics (ORKA) posted quarterly Change in Acquisitions & Divestments of $76.5 million for Q1 2026, down 12.27% year-over-year from $87.2 million in Q1 2025, and down 3.24% quarter-over-quarter from $79.0 million in Q4 2025.
Analysis
Oruka Therapeutics (ORKA) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Oruka Therapeutics' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $76.5 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 12.27% year-over-year to $76.5 million; the TTM figure through Mar 2026 stood at $413.7 million (up 374.62% YoY), while the FY2025 annual figure was $424.4 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $76.5 million, down from $79.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $145.3 million in Q3 2025, with the low at $76.5 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Oruka Therapeutics | 5.85 Bn | 4.12 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.60 Mn |
| Mar 31, 2026 | 76.47 Mn |
| Dec 31, 2025 | 79.03 Mn |
| Sep 30, 2025 | 145.33 Mn |
| Jun 30, 2025 | 112.89 Mn |
| Mar 31, 2025 | 87.17 Mn |
| Mar 31, 2018 | 3.05 Mn |
| Dec 31, 2017 | 4.75 Mn |
| Sep 30, 2017 | 2.50 Mn |
| Jun 30, 2017 | 6.60 Mn |
| Mar 31, 2017 | 4.55 Mn |
| Dec 31, 2016 | 3.15 Mn |
| Sep 30, 2016 | 500,000.00 |